BlackRock Inc. raised its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 0.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,780,976 shares of the medical instruments supplier’s stock after acquiring an additional 11,046 shares during the quarter. BlackRock Inc. owned about 9.00% of ICU Medical worth $307,218,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Nationwide Fund Advisors grew its position in ICU Medical by 18.4% in the second quarter. Nationwide Fund Advisors now owns 65,364 shares of the medical instruments supplier’s stock worth $11,275,000 after acquiring an additional 10,158 shares in the last quarter. Teachers Advisors LLC increased its stake in shares of ICU Medical by 0.9% during the 2nd quarter. Teachers Advisors LLC now owns 131,611 shares of the medical instruments supplier’s stock worth $22,703,000 after purchasing an additional 1,163 shares during the last quarter. Fiera Capital Corp acquired a new position in shares of ICU Medical during the 2nd quarter worth $36,962,000. Riverhead Capital Management LLC increased its stake in shares of ICU Medical by 99.8% during the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares during the last quarter. Finally, Martingale Asset Management L P increased its stake in shares of ICU Medical by 0.3% during the 2nd quarter. Martingale Asset Management L P now owns 38,703 shares of the medical instruments supplier’s stock worth $6,677,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 78.13% of the company’s stock.

A number of research analysts have recently weighed in on ICUI shares. Zacks Investment Research upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a report on Monday, September 11th. Sidoti lowered shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. BidaskClub cut shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Finally, Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $193.00.

TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/blackrock-inc-acquires-11046-shares-of-icu-medical-inc-icui/1602479.html.

In other ICU Medical news, CFO Scott E. Lamb sold 2,998 shares of the business’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $170.13, for a total transaction of $510,049.74. Following the sale, the chief financial officer now directly owns 9,050 shares of the company’s stock, valued at approximately $1,539,676.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Scott E. Lamb sold 23,772 shares of the stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $170.02, for a total transaction of $4,041,715.44. Following the transaction, the chief financial officer now owns 9,050 shares of the company’s stock, valued at $1,538,681. The disclosure for this sale can be found here. Insiders have sold 213,012 shares of company stock valued at $36,438,659 in the last 90 days. 15.90% of the stock is currently owned by corporate insiders.

Shares of ICU Medical, Inc. (ICUI) opened at 185.85 on Monday. ICU Medical, Inc. has a 1-year low of $124.68 and a 1-year high of $188.85. The stock’s 50 day moving average price is $173.09 and its 200 day moving average price is $164.39. The company has a market cap of $3.68 billion, a P/E ratio of 74.43 and a beta of 0.35.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). The business had revenue of $331.51 million during the quarter, compared to the consensus estimate of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The business’s revenue for the quarter was up 242.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.15 EPS. Equities research analysts forecast that ICU Medical, Inc. will post $4.11 earnings per share for the current year.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.